Clinical trial

Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine…

NCT00280111 · Society for Applied Studies, Other · Completed

Key facts

NCT number NCT00280111
Title Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants
Official title Reactogenicity and Immunogenicity of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Healthy Non-Malnourished Infants 8-12 Weeks of Age
Lead sponsor Society for Applied Studies, Other
Collaborators All India Institute of Medical Sciences National Institutes of Health (NIH) NIH Centers for Disease Control and Prevention U.S. Fed Stanford University Indian Institute of Science Children's Hospital…
Status Completed
Phase Phase 1
Study type Interventional
Conditions Rotavirus Infections
Intervention type Biological, Drug
Interventions 116E AGMK, I321, Placebo
Enrollment 90
Start date Jan 1, 2005
Primary completion May 1, 2005
Completion May 1, 2005
First posted Jan 20, 2006
Last update posted Jul 2, 2008
Countries India

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies